Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059939 · ClinicalTrials.gov registry record · NA
Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 542
- Enrollment target
NCT04059939: Completed NA study, sponsored by Boston University Charles River Campus.
NCT04059939 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 542 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04059939, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 542 participants
- Enrollment target
Study Summary
Despite decades of research on reading disabilities, little is known about improving reading in the middle grades (i.e., grades 3-6) and advancements have been hindered by the narrow focus on reading problems alone without acknowledgement of non-academic factors shown to affect learning (e.g., child self-regulation). This proposal employs a highly innovative approach aimed at improving intervention outcomes through the integration of evidence-based practices for addressing reading, as well as self-regulation/socioemotional skills, difficulties known to occur in a substantial percentage of struggling readers and to negatively influence academic performance. This project represents translational research that directly informs the practice community (schools, clinicians, teachers, parents), by identifying novel instructional practices that can be aggregated to more effectively influence student outcomes and reduce disparities in academic and socioemotional domains.
Primary Outcome
Measures "ability to pronounce printed words and phonemically regular nonwords accurately and fluently"
Interventions
- OTHER Reading
- BEHAVIORAL Anxiety Management
- OTHER Classroom Business as Usual
- OTHER Attention Control (math practice)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 542 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What the finished NCT04059939 record still lists
NCT04059939 is an interventional study that assigns participants to a tested intervention. The registered 542 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 4 interventions - of which Reading is the first listed.
NCT04059939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04059939 about?
NCT04059939 is a clinical study titled "Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers". Despite decades of research on reading disabilities, little is known about improving reading in the middle grades (i.e., grades 3-6) and advancements have been hindered by the narrow focus on reading problems alone without acknowledgement of non-academic factors shown to affect learning (e.g., child...
What is the current status of trial NCT04059939?
This trial is currently completed. It is a NA study. The enrollment target is 542 participants. The study started on 2017-08-01. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT04059939?
The interventions under investigation include: Reading (OTHER), Anxiety Management (BEHAVIORAL), Classroom Business as Usual (OTHER), Attention Control (math practice) (OTHER).
Who is sponsoring clinical trial NCT04059939?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04059939's enrollment target sits among peer trials
542 187th of 2000 higher than 1,814 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04929223 · 542 participants · Phase 1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- NCT05584670 · 542 participants · Phase 1
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
- NCT07294053 · 543 participants · NA
Sugary Drink Labeling Study
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI